RecruitingNCT06160284
Brain imaging before and after psilocybin in people receiving care for opioid use
About this title
Read the official source — NCT06160284Medication studyAges 25–55United StatesAddiction
Understand this study
Who could participate?
Listed age limits: 25 years to 55 years.
- Listed locations
- New HavenSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: May 28, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 12
- Sponsor
- Yale University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 25 Years to 55 Years
- Official registry ID
- NCT06160284
- Official title
Show the full official title
Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD)
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
New Haven
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Yale University, a university.
Does this study involve medication?
Yes. The study involves medication, including Psilocybin.
Who can participate?
Listed age limits: 25 years to 55 years.
Is this study still recruiting?
The registry lists this study as recruiting.
